$14.08
0[0.00%]
At close: May 3
$14.08
0[0.00%]
After Hours: 7:47PM EDT
Teva Pharmaceutical Indus
(NYSE:TEVA)Latest News for Teva Pharmaceutical Indus Stock (NYSE:TEVA)
Teva Pharmaceutical Indus Stock (NYSE: TEVA)
Categories: All
Wednesday, May 01, 2024
Monday, April 22, 2024
- US Supreme Court Declines To Hear Vanda Pharmaceuticals' Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, HetliozVandana Singh - Apr 22, 2024, 2:37PM
- 'The U.S Supreme Court Has Reportedly Declined To Hear Vanda Pharmaceuticals' Case Regarding The Invalidation Of Certain Patents For Its Sleep-Wake Disorder Drug Hetlioz, That Were Previously Declared Invalid In A Dispute With Generic Drugmakers Teva And Apotex' - Yahoo FinanceBenzinga Newsdesk - Apr 22, 2024, 12:05PM
Friday, April 19, 2024
Thursday, April 18, 2024
Tuesday, April 16, 2024
- Alvotech, Teva Announce US FDA Approval Of SELARSDI, Biosimilar To StelaraBenzinga Newsdesk - Apr 16, 2024, 5:33PM
- Teva's New Real-World Evidence Presented At The 2024 AAN Annual Meeting Confirms Effectiveness And Patient Satisfaction For HD Chorea With The 4-week Titration Kit For AUSTEDO TabletsBenzinga Newsdesk - Apr 16, 2024, 8:18AM
Friday, April 12, 2024
Wednesday, April 03, 2024
Wednesday, March 27, 2024
Tuesday, March 26, 2024
Monday, March 25, 2024
Thursday, March 21, 2024
Friday, March 08, 2024
Monday, March 04, 2024
Monday, February 26, 2024
- Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Feb 26, 2024, 1:57PM
- 10 Health Care Stocks With Whale Alerts In Today's SessionBenzinga Insights - Feb 26, 2024, 12:35PM
- Why Is Generic Drugs Player Teva Pharma Stock Trading Higher Today?Vandana Singh - Feb 26, 2024, 8:48AM
- Teva shares are trading higher after the company announced FDA approval of its arthritis treatment.Luke J Jacobi - Feb 26, 2024, 8:22AM
- Late Friday, Alvotech And Teva Pharmaceutical Industries Announced That FDA Approved Simlandi (Adalimumab-ryvk) Injection, As An Interchangeable Biosimilar To AbbVie's Arthritis Drug HumiraBenzinga Newsdesk - Feb 26, 2024, 7:22AM
- Teva Pharmaceutical Investments Singapore, A Subsidiary Of Teva Pharmaceutical Industries And Jiangsu Nhwa Pharmaceutical Formed A Partnership To Market And Distribute Teva's Austedo (Deutetrabenazine) For Neurodegenerative And Movement DisordersBenzinga Newsdesk - Feb 26, 2024, 7:08AM
- Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market SessionAvi Kapoor - Feb 26, 2024, 7:03AM
Tuesday, February 20, 2024
- Teva Pharma CEO Dismisses Split Speculations Expects Significant Interest For Its API Business Divestiture: ReportVandana Singh - Feb 20, 2024, 1:24PM
- Teva Presents New Data Supporting Safety, Tolerability And Target Engagement Of Anti-TL1A Antibody At The 2024 ECCO Annual MeetingBenzinga Newsdesk - Feb 20, 2024, 8:55AM
Monday, February 12, 2024
- Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo FranchisePriya Nigam - Feb 12, 2024, 11:53AM
- CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On MondayAvi Kapoor - Feb 12, 2024, 10:22AM
- Teva Pharmaceuticals shares are trading higher after Piper Sandler upgraded the stock from Neutral to Overweight and raised its price target from $12 to $19.Benzinga Newsdesk - Feb 12, 2024, 8:49AM
- Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For MondayAvi Kapoor - Feb 12, 2024, 7:43AM
- Beyond The Numbers: 8 Analysts Discuss Teva Pharmaceutical Indus StockBenzinga Insights - Feb 12, 2024, 7:00AM
- Piper Sandler Upgrades Teva Pharmaceutical Indus to Overweight, Raises Price Target to $19Benzinga Newsdesk - Feb 12, 2024, 5:29AM
Monday, February 05, 2024
Wednesday, January 31, 2024
- Teva Pharmaceutical Industries CEO Francis Says Still Expects U.S Humira Near Copy Launch, Despite AbbVie Holding Around 99% Of Market In 2023Benzinga Newsdesk - Jan 31, 2024, 12:21PM
- Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On WednesdayAvi Kapoor - Jan 31, 2024, 11:02AM
- Generic Drug Player Teva Pharma To Divest Its Active Pharmaceutical Ingredient Business, Q4 Earnings Surpass EstimatesVandana Singh - Jan 31, 2024, 10:14AM
- Teva Pharmaceuticals shares are trading lower after the company reported Q4 results and issued guidance.Benzinga Newsdesk - Jan 31, 2024, 8:53AM
- Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's PresserShanthi Rexaline - Jan 31, 2024, 7:46AM
- Teva Pharmaceutical Industries Sees 2024 Revenues Of $15.7B-$16.3B, With Adjusted EPS Of $2.20-$2.50 Versus Consensus Of $15.56B And $2.42, RespectivelyBenzinga Newsdesk - Jan 31, 2024, 7:05AM
- Teva Pharmaceutical Q4 Adjusted EPS $1.00 Beats $0.76 Estimate, Sales $4.46B Beat $3.99B EstimateBenzinga Newsdesk - Jan 31, 2024, 7:03AM
- Earnings Scheduled For January 31, 2024Benzinga Insights - Jan 31, 2024, 6:09AM
- Teva Announces Intention to Divest API Business as Part of Pivot to Growth StrategyBenzinga Newsdesk - Jan 31, 2024, 6:04AM
Tuesday, January 30, 2024
Monday, January 29, 2024
- Check Out What Whales Are Doing With TEVABenzinga Insights - Jan 29, 2024, 3:00PM
- Barclays Maintains Overweight on Teva Pharmaceutical Indus, Raises Price Target to $15Benzinga Newsdesk - Jan 29, 2024, 7:05AM
- Tech Titans Microsoft, Apple Lead 'Magnificent Seven' Earnings Wave This Week: Can Mega-Caps Ignite Market Optimism?Shanthi Rexaline - Jan 29, 2024, 5:51AM